NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 47335-0756-48 — Ipratropium and albuterol nebulizer solutionAI (151 hospitals, 54,772–55,771 samples)
• NDC 00487-0201-03 — Ipratropium-albuterol nebulizer solutionAI (311 hospitals, 54,772–55,771 samples)
• NDC 43598-0169-11 — Enalaprilat injection, 1.25 mg/mL intravenousAI (225 hospitals, 54,771–55,770 samples)
• NDC 36000-0162-01 — Norepinephrine intravenous solution, 1 mg/mLAI (223 hospitals, 54,759–55,767 samples)
• NDC 63402-0911-64 — Arformoterol 15 mcg/2 mL nebulizer solutionAI (194 hospitals, 54,759–55,767 samples)
• NDC 68180-0984-05 — Budesonide 0.5 mg/2 mL nebulizer suspensionAI (216 hospitals, 54,759–55,767 samples)
• NDC 00093-6816-45 — Budesonide inhalation solution for nebulizerAI (298 hospitals, 54,759–55,767 samples)
• NDC 36000-0149-01 — Flumazenil injection (0.1 mg/mL)AI (98 hospitals, 54,759–55,767 samples)
• NDC 70121-1637-07 — Ephedrine sulfate injection, 50 mg/mLAI (184 hospitals, 54,759–55,767 samples)
• NDC 00378-9671-64 — Ipratropium and albuterol nebulizer solutionAI (93 hospitals, 54,771–55,761 samples)
• NDC 00378-8270-64 — Albuterol sulfate 2.5 mg nebulizer solutionAI (110 hospitals, 54,769–55,759 samples)
• NDC 76204-0900-25 — Levalbuterol inhaled nebulizer solutionAI (203 hospitals, 54,758–55,757 samples)
• NDC 51754-0204-04 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (125 hospitals, 54,758–55,757 samples)
• NDC 55150-0373-25 — Ephedrine sulfate 50 mg/mL injection solutionAI (107 hospitals, 54,758–55,757 samples)
• NDC 72485-0108-05 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (181 hospitals, 54,758–55,757 samples)
• NDC 63323-0694-44 — Acetylcysteine 20% solutionAI (201 hospitals, 54,757–55,747 samples)
• NDC 63402-0911-01 — Arformoterol 15 mcg/2 mL nebulizer solutionAI (258 hospitals, 54,757–55,747 samples)
• NDC 69097-0840-34 — Ipratropium and albuterol nebulizer solutionAI (145 hospitals, 54,757–55,747 samples)
• NDC 70756-0612-60 — Arformoterol 15 mcg/2 mL nebulizer solutionAI (79 hospitals, 54,757–55,747 samples)
• NDC 63323-0690-41 — Acetylcysteine 20% solutionAI (108 hospitals, 54,757–55,747 samples)
• NDC 63402-0911-04 — Arformoterol 15 mcg per 2 mL nebulizer solutionAI (142 hospitals, 54,757–55,747 samples)
• NDC 63323-0694-41 — Acetylcysteine 20% solutionAI (148 hospitals, 54,757–55,747 samples)
• NDC 47335-0756-49 — Ipratropium and albuterol nebulizer solutionAI (193 hospitals, 54,757–55,747 samples)
• NDC 62756-0277-01 — Arformoterol 15 mcg/2 mL nebulizer solutionAI (90 hospitals, 54,757–55,747 samples)
• NDC 63323-0690-44 — Acetylcysteine 20% solutionAI (100 hospitals, 54,757–55,747 samples)
• NDC 67457-0181-00 — Ketamine injection syringeAI (211 hospitals, 54,757–55,747 samples)
• NDC 70121-1576-01 — Norepinephrine intravenous solution, 1 mg/mLAI (237 hospitals, 54,757–55,747 samples)
• NDC 72485-0108-01 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (185 hospitals, 54,757–55,747 samples)
• NDC 00781-3495-95 — Dexmedetomidine IV infusion in salineAI (147 hospitals, 54,757–55,747 samples)
• NDC 00115-9932-76 — Levalbuterol 1.25 mg nebulizer solutionAI (95 hospitals, 54,757–55,747 samples)
• NDC 00378-8270-62 — Albuterol sulfate 2.5 mg nebulizer solutionAI (74 hospitals, 54,757–55,747 samples)
• NDC 00409-3375-14 — Norepinephrine 1 mg/mL intravenous solutionAI (245 hospitals, 54,757–55,747 samples)
• NDC 00409-9045-11 — Bupivacaine with epinephrine injectionAI (165 hospitals, 54,757–55,747 samples)
• NDC 00409-9046-11 — Bupivacaine with epinephrine injection solutionAI (69 hospitals, 54,757–55,747 samples)
• NDC 00990-7715-12 — MANNITOL 20 % INTRAVENOUS SOLUTIONAI (232 hospitals, 54,757–55,747 samples)
• NDC 55150-0342-01 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (94 hospitals, 54,757–55,747 samples)
• NDC 55150-0373-01 — Ephedrine sulfate injection, 50 mg/mLAI (91 hospitals, 54,757–55,747 samples)
• NDC 63323-0460-01 — Bupivacaine with epinephrine, preservative-free 0.75% injectionAI (102 hospitals, 54,757–55,747 samples)
• NDC 65219-0065-02 — ROCURONIUM 10 MG/ML INTRAVENOUS SOLUTIONAI (63 hospitals, 54,757–55,747 samples)
• NDC 65219-0447-02 — Etomidate 2 mg/mL intravenous solutionAI (191 hospitals, 54,757–55,747 samples)
• NDC 70069-0272-01 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (51 hospitals, 54,757–55,747 samples)
• NDC 70069-0272-05 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (84 hospitals, 54,757–55,747 samples)
• NDC 72266-0147-01 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (201 hospitals, 54,757–55,747 samples)
• NDC 63323-0321-01 — Polymyxin B sulfate injection, 500,000 unitsAI (155 hospitals, 54,757–55,747 samples)
• NDC 62756-0277-02 — Arformoterol 15 mcg nebulizer solutionAI (129 hospitals, 54,757–55,747 samples)
• NDC 00781-3495-46 — Dexmedetomidine IV infusion in salineAI (140 hospitals, 54,757–55,747 samples)
• NDC 23155-0160-32 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (66 hospitals, 54,757–55,747 samples)
• NDC 00378-9671-60 — Ipratropium and albuterol nebulizer solutionAI (81 hospitals, 54,757–55,747 samples)
• NDC 66993-0023-35 — Levalbuterol 1.25 mg nebulizer solutionAI (81 hospitals, 54,757–55,747 samples)
• NDC 66993-0023-27 — Levalbuterol inhalation solution for nebulizerAI (181 hospitals, 54,757–55,747 samples)